Skip to content

Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain

Access to Chiropractic Care During the State of Emergency Generated by the COVID-19 Pandemic in Spain: a Pragmatic Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04573361
Enrollment
723
Registered
2020-10-05
Start date
2020-05-02
Completion date
2020-05-27
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disability Physical, Musculoskeletal Pain, Psychological Distress

Brief summary

This is a pragmatic controlled clinical trial taking place in the first phase of COVID-19 lockdown re-opening in Spain. Patients of 52 chiropractic clinics were invited to participate in a pseudo-random order (one out of every three contacted patients) as they were contacted to either schedule an appointment with their current chiropractor or not, depending on the clinic's and the patient's availability. Patients would receive chiropractic in-person care (one or more than one visits) or no care at all, for a two-week period. According to the care received, they were assigned to one of three groups (receiving no care, receiving care once, and more than once). Participants filled an online questionnaire with self-reported outcome-measures at the beginning of the two week period. A follow-up questionnaire was completed 14 days after.

Interventions

OTHERChiropractic care (one visit)

One visit to the chiropractor based on the use of spinal manipulative therapy, mobilization and other forms of manual therapy, exercise therapy, patient education, advice and reassurance

OTHERChiropractic care (more than one visit)

More than one visit to the chiropractor based on the use of spinal manipulative therapy, mobilization and other forms of manual therapy, exercise therapy, patient education, advice and reassurance

Sponsors

Université du Québec à Trois-Rivières
CollaboratorOTHER
University of Birmingham
CollaboratorOTHER
Real Centro Universitario Maria Cristina
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Care was provided by chiropractors,

Intervention model description

Three arms depending on the access to chiropractic care (no access, one visit or more than one) during the 14-days period of the trial. Measures were taken at the beginning and at the end of the 14-day period.

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chiropractic patients active when lockdown was declared, over the age of 14

Exclusion criteria

* new patients in the clinic, patients with no current pain at the time of the trial

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity14 daysNumerical rating scale (0-10, 0 meaning no pain, 10 meaning worst pain imaginable)
Pain frequency14 daysLikert Scale from better (1) to worst (4) outcomes, 1: occasionally, 4: constantly
Pain evolution14 daysLikert Scale of self-perceived improvement, from better (1) to worst (5) outcomes, 1: much better, 5: much worse
Pain interference14 daysValidated subscale form the Brief Pain Inventory, 6 categories from 0 to 10 each, the lower, the better outcomes, out of a minimal of 0 and total of 60.

Secondary

MeasureTime frameDescription
Pain Catastrophizing Scale14 daysValidated questionnaire. Short version 4 items, Likert scale from 0 to 4, lowest score (0) better outcomes, highest score (16) worst outcomes
Tampa Scale Kinesiophobia14 daysValidated questionnaire. Short version 11 items, Likert scale from 1 to 4, lowest score (11) better outcomes, highest score (44) worst outcomes
General Anxiety Disorder scale14 daysValidated questionnaire 7 items, Likert scale from 0 to 3, lowest score (0) better outcomes, highest score (21) worst outcomes
Intolerance of Uncertainty Scale14 daysValidated questionnaire. Short version 12 items, Likert scale from 1 to 5, lowest score (12) better outcomes, highest score (60) worst outcomes
General Self-Efficacy scale14 daysValidated questionnaire 10 items, Likert scale from 1 to 10, lowest score (10) WORST outcomes, highest score (100) BETTER outcomes
Fear of Illness and Virus Evaluation14 daysQuestionnaire, subscale 10 items, Likert scale from 1 to 4, lowest score (1) WORST outcomes, highest score (40) BETTER outcomes

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026